Consorzio per Valutazioni Biologiche e Farmacologiche and the Athena Research and innovation center in information communication & knowledge technologies are pleased to launch the first international annual meeting on pediatrics & rare diseases, that will be held in Athens from December 16th to December 17th, 2019. The Greek local chapter of the Controlled Release Society is participating as co-
In our days, drug development is undergoing a paradigm shift with an increasing emphasis on understanding pathology at the molecular and systems biology levels leading to more targeted therapies with disease modifying properties. There are also moves towards greater forward and reverse integration of the stages of drug development, building on the application of modelling and simulation from discovery to clinical trial. Improved integration of the development and regulation of diagnostics, drugs and devices is a clear need in making innovation more patient-centric and personalized.
Children and young patients are not little adults and they cannot be compared with adults as they are growing up and their metabolism is different. For this reason, the only way to develop better medicines for children and young patients is studying them specifically for this type of “special” population. In this context. EPTRI (European Pediatric Translational Research Infrastructure – https://www.eptri.eu) aims to create the framework for a new Research Infrastructure intended to
enhance technology-driven pediatric research in drug discovery and early development phases to be translated into clinical research and pediatric use of medicines.
I would highly appreciate if you could inform the members of your Society about this meeting, by including info about the event in your future newsletters and/or post the banner of the event on the official website of the Society.
Also, we would like to include your society to the Supporting Societies section, so please be so kind to send us your logo in high resolution. For more information regarding the Congress, please visit the official website www.pediatricrarediseases2019.com.
Looking forward to your positive answer, we thank you in advance for your consideration and we remain at your disposal for any further information or clarification.
Mr. Donato Bonifazi, CEO, Consorzio per Valutazioni
Biologiche e Farmacologiche
Emeritus Professor Panos Macheras,
Head, Pharmainformatics Unit, Athena